MYLAN TM 250 MYLAN TM 250 Pill - white capsule/oblong, 21mm
Pill with imprint MYLAN TM 250 MYLAN TM 250 is White, Capsule/Oblong and has been identified as Temozolomide 250 mg. It is supplied by Mylan Pharmaceuticals Inc.
Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN TM 250 MYLAN TM 250
Temozolomide
- Imprint
- MYLAN TM 250 MYLAN TM 250
- Strength
- 250 mg
- Color
- White
- Size
- 21.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-5265 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
lactose anhydrous,
sodium starch glycolate type A potato,
stearic acid,
tartaric acid,
ammonia,
ferrosoferric oxide,
propylene glycol,
shellac,
gelatin,
titanium dioxide,
sodium lauryl sulfate
Note: Inactive ingredients may vary.
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
